Cargando…

Rapid-Onset Anti-Stress Effects of a Kappa-Opioid Receptor Antagonist, LY2795050, Against Immobility in an Open Space Swim Paradigm in Male and Female Mice

The kappa-opioid receptor (KOR) / dynorphin system is implicated with behavioral and neurobiological effects of stress exposure (including heavy exposure to drugs of abuse) in translational animal models. Thus some KOR-antagonists can decrease the aversive, depressant-like and anxiety-like effects c...

Descripción completa

Detalles Bibliográficos
Autores principales:	Baynard, Caroline, Prisinzano, Thomas E., Butelman, Eduardo R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8645979/ https://www.ncbi.nlm.nih.gov/pubmed/34880762 http://dx.doi.org/10.3389/fphar.2021.775317

Ejemplares similares

Repeated Administration of Opra Kappa (LY2456302), a Novel, Short-Acting, Selective KOP-r Antagonist, in Persons with and without Cocaine Dependence
por: Reed, Brian, et al.
Publicado: (2018)

Sex Differences in the Effects of a Kappa Opioid Receptor Antagonist in the Forced Swim Test
por: Laman-Maharg, Abigail, et al.
Publicado: (2018)

Challenging the thorium-immobility paradigm
por: Nisbet, Haylea, et al.
Publicado: (2019)

Determining Pharmacological Selectivity of the Kappa Opioid Receptor Antagonist LY2456302 Using Pupillometry as a Translational Biomarker in Rat and Human
por: Rorick-Kehn, Linda M., et al.
Publicado: (2015)

Design, synthesis, and preliminary evaluation of a potential synthetic opioid rescue agent
por: Hedrick, Sidnee L., et al.
Publicado: (2021)

The effect of GABAmimetics on the duration of immobility in the forced swim test in albino mice
por: El zahaf, Najwa Ahmed, et al.
Publicado: (2014)

Major Depressive Disorder and Kappa Opioid Receptor Antagonists
por: Li, Wei, et al.
Publicado: (2016)

Salvinorin A, a kappa-opioid receptor agonist hallucinogen: pharmacology and potential template for novel pharmacotherapeutic agents in neuropsychiatric disorders
por: Butelman, Eduardo R., et al.
Publicado: (2015)

Corrigendum: Salvinorin A, a kappa-opioid receptor agonist hallucinogen: pharmacology and potential template for novel pharmacotherapeutic agents in neuropsychiatric disorders
por: Butelman, Eduardo R., et al.
Publicado: (2015)

Chronic Peripheral Administration of Kappa-Opioid Receptor Antagonist Advances Puberty Onset Associated with Acceleration of Pulsatile Luteinizing Hormone Secretion in Female Rats
por: NAKAHARA, Tatsuo, et al.
Publicado: (2013)

The Kappa Opioid Receptor Agonist 16-Bromo Salvinorin A Has Anti-Cocaine Effects without Significant Effects on Locomotion, Food Reward, Learning and Memory, or Anxiety and Depressive-like Behaviors
por: van de Wetering, Ross, et al.
Publicado: (2023)

Behavioral Pharmacology of Novel Kappa Opioid Receptor Antagonists in Rats
por: Page, Sarah, et al.
Publicado: (2019)

Sex Differences in Kappa Opioid Receptor Agonist Mediated Attenuation of Chemotherapy-Induced Neuropathic Pain in Mice
por: Paton, Kelly F., et al.
Publicado: (2022)

Antidepressant-Like Effects of Lindera obtusiloba Extracts on the Immobility Behavior of Rats in the Forced Swim Test
por: Lim, Dong Wook, et al.
Publicado: (2016)

Characterization of Pyrrolidinyl-hexahydro-pyranopiperazines as a Novel Kappa Opioid Receptor Agonist Scaffold
por: Reed, Brian, et al.
Publicado: (2022)

In Vitro, In Vivo and In Silico Characterization of a Novel Kappa-Opioid Receptor Antagonist
por: Puls, Kristina, et al.
Publicado: (2022)

ThermoMaze: A behavioral paradigm for readout of immobility-related brain events
por: Vöröslakos, Mihály, et al.
Publicado: (2023)

Conscious Immobility
por: de M. Rudolf, G.
Publicado: (1964)

Immobility of the Jaws
Publicado: (1871)

Group II mGlu receptor antagonist LY341495 enhances the antidepressant-like effects of ketamine in the forced swim test in rats
por: Podkowa, Karolina, et al.
Publicado: (2016)

Sex-Specific Diurnal Immobility Induced by Forced Swim Test in Wild Type and Clock Gene Deficient Mice
por: Li, Ningyue, et al.
Publicado: (2015)

Discovery of the First Small-Molecule Opioid Pan Antagonist with Nanomolar Affinity at Mu, Delta, Kappa, and Nociceptin Opioid Receptors
por: Zaveri, Nurulain T., et al.
Publicado: (2015)

Immobility or Closure of the Jaw
por: Westmoreland, W. F.
Publicado: (1876)

Immobility Following Influenza
por: Hoskins, W. Horace
Publicado: (1895)

Ly49 Receptors: Innate and Adaptive Immune Paradigms
por: Rahim, Mir Munir A., et al.
Publicado: (2014)

Effects of periadolescent fluoxetine and paroxetine on elevated plus-maze, acoustic startle, and swimming immobility in rats while on and off-drug
por: Vorhees, Charles V, et al.
Publicado: (2011)

Gunn rats with glial activation in the hippocampus show prolonged immobility time in the forced swimming test and tail suspension test
por: Arauchi, Ryosuke, et al.
Publicado: (2018)

Aticaprant (Clinically Developed Kappa-Opioid Receptor Antagonist) Combined With Naltrexone Prevents Alcohol “Relapse” Drinking
por: Zhou, Y, et al.
Publicado: (2022)

Kappa opioid receptor antagonist and N-methyl-D-aspartate receptor antagonist affect dynorphin-induced spinal cord electrophysiologic impairment☆
por: Chen, Yu, et al.
Publicado: (2012)

Pharmacological profiles of opioid ligands at Kappa opioid receptors
por: Gharagozlou, Parham, et al.
Publicado: (2006)

Probing ligand recognition of the opioid pan antagonist AT-076 at nociceptin, kappa, mu, and delta opioid receptors through structure-activity relationships
por: Journigan, V. Blair, et al.
Publicado: (2017)

ON THE MECHANISM OF TONIC IMMOBILITY IN VERTEBRATES
por: Hoagland, Hudson
Publicado: (1928)

Partial Immobility of the Orbicularis Oris
Publicado: (1849)

Immobility in the Treatment of Diseases of Extremities
por: Williams, W. L.
Publicado: (1895)

Assessing Post-Traumatic Tonic Immobility Responses: The Scale for Tonic Immobility Occurring Post-Trauma
por: Lloyd, Chantelle S., et al.
Publicado: (2019)

Use of Remifentanil in a Novel Clinical Paradigm to Characterize Onset and Duration of Opioid Blockade by Samidorphan, a Potent μ-Receptor Antagonist
por: Shram, Megan J., et al.
Publicado: (2015)

Therapeutic Potential of Kappa Opioid Agonists
por: Beck, Tyler C., et al.
Publicado: (2019)

Differential effects of novel kappa opioid receptor antagonists on dopamine neurons using acute brain slice electrophysiology
por: Margolis, Elyssa B., et al.
Publicado: (2020)

Antidepressant-Like Effects of the Ethyl Acetate Soluble Fraction of the Root Bark of Morus alba on the Immobility Behavior of Rats in the Forced Swim Test
por: Lim, Dong Wook, et al.
Publicado: (2014)

Ketamine Reverses Lateral Habenula Neuronal Dysfunction and Behavioral Immobility in the Forced Swim Test Following Maternal Deprivation in Late Adolescent Rats
por: Shepard, Ryan D., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_vgl5n2j77bpm19a5gvgtsk5gq1